-
Bristol-Myers racks up Opdivo combo data to sell its new biomarker, but will doctors buy it?
fiercepharma
June 05, 2018
Bristol-Myers Squibb’s new strategy In lung cancer relies on showing its new biomarker can help predict who benefits most from immunotherapy combinations.
-
Women's hormone drug prices have climbed for years, but controversy hasn't ensued. Why?
fiercepharma
June 05, 2018
Another case hasn't garnered the same attention—and maybe that's because people just don't like to talk about vaginas.
-
AstraZeneca heads to 2018 ASCO Annual Meeting with its diversified oncology portfolio and next-generation pipeline
worldpharmanews
June 05, 2018
AstraZeneca and MedImmune, its global biologics research and development arm, head to the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago
-
Study finds antioxidant-enriched vitamin reduces respiratory illnesses in patients with CF
worldpharmanews
June 05, 2018
Researchers at Children's Hospital Colorado (Children's Colorado) and the University of Colorado School of Medicine have found that taking a specially formulated antioxidant-enriched multivitamin may decrease respiratory illnesses in people with cystic fi
-
Spiolto® Respimat® enables greater physical activity in people living with Chronic Obstructive Pulmonary Disease
worldpharmanews
June 05, 2018
Boehringer Ingelheim announced data which add to the growing body of evidence that show Spiolto® (tiotropium/olodaterol) Respimat® enables greater physical activity in patients living with COPD.
-
Antidepressant use may contribute to long-term population weight gain
worldpharmanews
June 05, 2018
Researchers at King's College London have found that patients prescribed any of the 12 most commonly used antidepressants were 21% more likely to experience an episode of gain weight than those not taking the drugs
-
Pfizer begins a Phase 1/2 study to evaluate respiratory syncytial virus (RSV) vaccine
worldpharmanews
June 05, 2018
Pfizer Inc. (NYSE:PFE) today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways
-
Study demonstrates new treatment for severe asthma
worldpharmanews
June 05, 2018
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton
-
Eczema drug effective against severe asthma
worldpharmanews
June 05, 2018
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies.
-
Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer
worldpharmanews
June 05, 2018
Novartis will present data from across its oncology portfolio at the upcoming 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held June 1-5 in Chicago